ArticleBMC musculoskeletal disorders2025
Nodular amyloid deposits with collagen fibre rupture in tenosynovial carpal tissues are associated with transthyretin cardiomyopathy: a single-centre prospective diagnostic study.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSystemic amyloidosis affects various organs, including soft tissues, with cardiac involvement (ATTR-CM) associated with the poorest prognosis. Because current treatments are most effective in the early stages, early diagnosis is essential. However, little is known about the significance of distinct morphological patterns of amyloid deposits in musculoskeletal red flag lesions, including the bilateral carpal tunnel tissues. The primary objective of this study was to evaluate the incidence and morphological patterns of amyloidosis in patients with bilateral carpal tunnel syndrome; the secondary aim was to screen for cardiac forms. We proposed a novel three-tiered histopathological classification of amyloid deposits within carpal tenosynovial tissues.
methodsFrom June 2021 until May 2023, we conducted a single-centre prospective diagnostic study to investigate microscopic patterns of amyloid deposits in tenosynovial tissues obtained during open median nerve release surgery in patients with bilateral carpal tunnel syndrome. Our study cohort included 83 patients (42 women, 41 men), with a mean age of 65.7 years (range, 27–89 years). All patients underwent a cardiac examination. Scintigraphy and endomyocardial biopsy were performed in highly suspicious cases.
resultsAmyloid deposits were identified in Congo red-stained specimens from 24 patients (28.9%; 16 men and 8 women) and categorised as linear (n = 12), nodular (n = 5), or nodular with collagen fibre rupture (n = 7). The semiquantitative assessed amyloid burden did not correlate with the histologic types of amyloid. Scintigraphy and endomyocardial biopsy were performed in three male patients and confirmed a wild-type form of ATTR-CM. All three patients showed type 3 nodular amyloid deposits with collagen rupture in their carpal tissues. Although the extent of amyloid deposition in tenosynovial tissues did not correlate with cardiac involvement, we observed an association between the nodular pattern with collagen fibre rupture (type 3) and the presence of wild-type ATTR-CM.
conclusionsWe defined three distinct morphological types of amyloid deposition in tenosynovial tissues. The type 3 nodular pattern with collagen fibre rupture appeared to be associated with ATTR-CM. This proposed histopathological classification might significantly enhance screening for ATTR-CM in patients with bilateral carpal tunnel syndrome. Our exploratory findings require validation in larger studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.